Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

35
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
35
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

46
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
46
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

226
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
226
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.3K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

424
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
424
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

298
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
298

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific systemic and brain metabolic responses to a standardized ketogenic diet in mice.

Lab animal·2026
Same author

A multimodal spatial atlas of transcriptomic, morphological, and electrophysiological cell type densities in the mouse brain.

PLoS computational biology·2026
Same author

Modeling and simulation of neocortical micro- and mesocircuitry (Part I, anatomy).

eLife·2026
Same author

Modeling and simulation of neocortical micro- and mesocircuitry (Part II, Physiology and experimentation).

eLife·2026
Same author

An extended and improved CCFv3 annotation and Nissl atlas of the entire mouse brain.

Imaging neuroscience (Cambridge, Mass.)·2025
Same author

A multiscale electro-metabolic model of a rat neocortical circuit reveals the impact of ageing on central cortical layers.

PLoS computational biology·2025
Same journal

New approach methodologies as first tier in an integrated approach to testing and assessment for non-genotoxic carcinogens.

ALTEX·2026
Same journal

Assessing the FDA's Year One Progress Report on Reducing Animal Testing.

ALTEX·2026
Same journal

Europe's roadmap finally arrives: Long on rigor, short on a clock.

ALTEX·2026
Same journal

Towards advanced in vitro models of testicular steroidogenesis for endocrine disruption testing.

ALTEX·2026
Same journal

Evaluation of EndoSens: A reliable skin sensitization assessment model.

ALTEX·2026
Same journal

Serum-free in vitro assessment of receptor-mediated endocrine activity including Phase-1 metabolism.

ALTEX·2026
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
10:33

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates

Published on: February 23, 2018

26.2K

[Pharmacokinetic Simulations for Teaching]

Daniel Keller1

  • 1Departement Pharmazie, ETH, CH-Zürich.

ALTEX
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

PharmaSim is a new pharmacokinetic simulation program for visualizing drug plasma levels. Its rapid, interactive simulations and electronic textbook format enhance understanding of parameter effects.

More Related Videos

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
Visualizing Hyporheic Flow Through Bedforms Using Dye Experiments and Simulation
09:49

Visualizing Hyporheic Flow Through Bedforms Using Dye Experiments and Simulation

Published on: November 18, 2015

12.9K

Related Experiment Videos

Last Updated: Feb 26, 2026

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
10:33

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates

Published on: February 23, 2018

26.2K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
Visualizing Hyporheic Flow Through Bedforms Using Dye Experiments and Simulation
09:49

Visualizing Hyporheic Flow Through Bedforms Using Dye Experiments and Simulation

Published on: November 18, 2015

12.9K

Area of Science:

  • Pharmacokinetics
  • Computational Biology
  • Drug Development

Background:

  • Pharmacokinetic (PK) modeling is crucial for understanding drug behavior in the body.
  • Visualizing the impact of PK parameters on drug plasma levels can be challenging with traditional methods.
  • Existing simulation tools may lack speed and interactive visualization capabilities.

Purpose of the Study:

  • To introduce PharmaSim, a novel pharmacokinetic simulation program.
  • To highlight PharmaSim's capabilities in simulating drug plasma levels using compartment models.
  • To emphasize the program's advantages in rapid, interactive visualization and educational tool creation.

Main Methods:

  • Development of PharmaSim, a software program for pharmacokinetic simulations.
  • Implementation of compartment models for simulating drug plasma concentrations.
  • Integration of near real-time parameter adjustment visualization (delay time < 0.1 sec).
  • Embedding simulations within a HyperCard-based electronic book for tutorials.

Main Results:

  • PharmaSim enables rapid simulation of drug plasma levels.
  • The software provides near instant visual feedback when parameters are altered.
  • PharmaSim facilitates clear illustration of how individual parameters influence simulation outcomes.
  • The program supports the creation of customizable tutorials through script files.

Conclusions:

  • PharmaSim offers a significant advancement in pharmacokinetic simulation software.
  • Its interactive visualization and speed enhance the understanding of PK principles.
  • PharmaSim serves as a versatile tool for both research and educational purposes in pharmacology.